Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Wells HRR, Newman TA, Williams FMK
Title: SARC031: A Phase 2 Trial of the MEK Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Combination with the mTOR Inhibitor Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors Status: Recruiting For more information about this trial, contact: AeRang Kim, M.D., Ph.D
Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the age-related eye disease study
Glutathione is recognized as the bodys master antioxidant , playing critical roles in cellular protection , detoxification , and immune function
Yes, once your appointment for infusion is booked we will schedule your consultation with our provider at the same time
US$ 24.59
US$ 20.04
US$ 20.18
US$ 28.78
US$ 25.00
US$ 29.90
